Our technologies are completely unique in the industry and can be used to produce a wide array of products, each having specific characteristics and applications.
UNPREDICTABLE & LENGHTY ONSET
HIGHLY PREDICTABLE & RAPID ONSET
SINGLE FORMAT DOSAGE
BUSINESS MODEL DRIVEN DOSAGE MODEL
Infuz2O solves major hurdles and unlocks massive potential of the Cannabis Beverage Market
Our Infuz2O and Bio-Natural Oils have excellent flexibility when it comes to formulation. Infusion Biosciences has the technology and know-how necessary to create the next generation of superior formulations across every cannabis category that exists today.
APP Recovery Process can be formulated into any of the products available today in addition to proving the only truly water-soluble cannabis product
Innovation and Development of Phytopharmaceuticals
Infusion Biosciences (IB) is using a patent pending technology to produce water soluble phytochemicals from cannabis and hemp plant varieties. The water solutions produced from unique plants contain a distinct entourage of phytochemicals that are reported to provide medicinal benefits including relief from pain and anxiety, appetite control, and biochemical pathways underlying inflammation, liver diseases, and cancer. Adverse effects arising from current delivery methods (smoking, vaporization, and most edibles) limit prescription and non-prescription uses of phytochemicals from cannabis plants for medicinal purposes in a growing majority of individuals.
Current consumer products are limited to extracted oils that can only be delivered in vaporizers and selected edibles. Product benefit claims are now based on only determining a few cannabinoids without rigorous quality control analysis. The inability to deliver the current products in true water solutions is a major impediment to controlling the dose and reproducibility needed for desired nutritional and medicinal use of cannabis products. Water or beverage products are currently limited to the use of emulsifiers or oil nanoparticles and not true solutions in water. These not only limit proper delivery to the body but also prevent a broader acceptance of the current products.
There is a long history of successful development of biopharmaceutical drugs based on compounds isolated from plants and other natural sources. Phytochemical preparations produced from cannabis varieties hold significant promise as products to support a healthy and positive lifestyle to alleviate the side effects of traditional drug treatments or from chronic conditions that result in a lower quality of life.
IB’s strategy is built on the principles of biotechnology that witnessed the successful development of numerous naturally occurring molecules. Examples include insulin, therapeutic blood proteins (such as Factor VIII and antibodies), anti-anemia biopharmaceutical erythropoietin (originally isolated from human urine), and anticancer drugs from plants (such as taxol, homoharringtonine and camptothecin).
IB has completed the production of entourage of phytochemicals from multiple cannabis plant varieties and established bioactivities previously reported from smoking the oil-rich portions of these plants. The patent pending Aqueous Phytorecovery Process (APP) is effective in producing true water solutions of the bioactive molecules from multiple parts of the plants. The “liquid” cannabis preparations produced by APP display fast, predictable, and dose dependent effects in a large number of recreational and medicinal cannabis users. This is consistent with the pharmacology of orally administered bioactive molecules dissolved in water and is distinct from the administration of oil preparations that have become customary in the industry.